We are thrilled to share that the European project EUCanScreen: Joint European Action for the Implementation of Cancer Screening Programs in the EU was presented at the 5th Panhellenic Congress “Present and Future in Oncology” on June 12th, 2025.
Event Details
The event was held at the Achaia Beach Hotel in Patras and organized by the Hellenic Society of Geriatric Oncology in collaboration with prominent organizations, including the Oncology Department of the Pathology Clinic of the University General Hospital of Patras, ESYN/HeCOG. It was held under the auspices of the Society of Oncologists of Greece and the Patras Medical Association.
Key Participation
Dr. Anna Vicha, a respected member of the scientific team from the 6th DYPEDE and Head of Diary Hospitalization at the University General Hospital of Patras, represented the EUCanScreen project during the event.
Greece plays an active role in EUCanScreen through the Ministry of Health and the 6th DYPEDE entity. Professor Apostolos Vantarakis, from the Department of Medicine of the University of Patras, leads Work Package 2 (Dissemination) and contributes significantly to all work packages.
About EUCanScreen
EUCanScreen aims to ensure the sustainability of high-quality cancer screening programs across Europe, including breast, cervical, colorectal, lung, prostate, and stomach cancers. Its mission is to reduce cancer rates and achieve healthcare equality for all EU citizens.
Together, we strive for a healthier future!
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959